Literature DB >> 21496600

Essential tremor.

Elan D Louis1.   

Abstract

Essential tremor (ET) is among the most common neurological disorders. This chapter reviews the epidemiology, clinical features, and pathophysiology of ET. The defining feature is a kinetic tremor of the arms. Patients often have a postural tremor as well. Other body regions may also be involved (especially the head). The severity of tremor may range from mild cases in population settings to more severe cases in treatment settings. Motor features aside from tremor have been described in ET, including tandem gait difficulty. Mild cognitive changes (especially executive dysfunction) have been documented in many studies as well. Despite being regarded as one of the most common hyperkinetic movement disorders, establishing a precise prevalence has been difficult, yet the prevalence among persons aged 40 and older seems to be 4% or higher. There are numerous examples of families in which the disease appears to be inherited yet genetic studies have not progressed to the point where ET genes have been identified. There is also a growing understanding that environmental factors are likely to contribute to the etiology of ET. More recent postmortem studies have helped localize the possible source of ET to structural alterations in the cerebellum and its connecting pathways.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21496600     DOI: 10.1016/B978-0-444-52014-2.00033-1

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  11 in total

1.  Functional Brain Activity Relates to 0-3 and 3-8 Hz Force Oscillations in Essential Tremor.

Authors:  Kristina A Neely; Ajay S Kurani; Priyank Shukla; Peggy J Planetta; Aparna Wagle Shukla; Jennifer G Goldman; Daniel M Corcos; Michael S Okun; David E Vaillancourt
Journal:  Cereb Cortex       Date:  2014-06-24       Impact factor: 5.357

Review 2.  The Role of β-Carboline Alkaloids in the Pathogenesis of Essential Tremor.

Authors:  Svetlana Iuliana Laviță; Rania Aro; Béla Kiss; Mario Manto; Pierre Duez
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

3.  A noninvasive handheld assistive device to accommodate essential tremor: a pilot study.

Authors:  Anupam Pathak; John A Redmond; Michael Allen; Kelvin L Chou
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

Review 4.  Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-05-03

5.  Tremor: clinical phenomenology and assessment techniques.

Authors:  Christopher W Hess; Seth L Pullman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-06-28

6.  Cognitive features of essential tremor: a review of the clinical aspects and possible mechanistic underpinnings.

Authors:  Félix Bermejo-Pareja; Verónica Puertas-Martín
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-14

7.  Evaluating Familial Essential Tremor with Novel Genetic Approaches: Is it a Genotyping or Phenotyping Issue?

Authors:  Pedro Gonzalez-Alegre; Jorge Di Paola; Kai Wang; Shay Fabbro; Hung-Chun Yu; Tamim H Shaikh; Benjamin W Darbro; Alexander G Bassuk
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-10-20

8.  Decreased EAAT2 protein expression in the essential tremor cerebellar cortex.

Authors:  Michelle Lee; Melody M Cheng; Chi-Ying Lin; Elan D Louis; Phyllis L Faust; Sheng-Han Kuo
Journal:  Acta Neuropathol Commun       Date:  2014-11-13       Impact factor: 7.801

9.  How to tackle tremor - systematic review of the literature and diagnostic work-up.

Authors:  A W G Buijink; M F Contarino; J H T M Koelman; J D Speelman; A F van Rootselaar
Journal:  Front Neurol       Date:  2012-10-23       Impact factor: 4.003

10.  Essential Tremor Prevalence is Low in the Druze Population in Northern Israel.

Authors:  Judith Aharon-Peretz; Samih Badarny; Raphiq Ibrahim; Ruth Gershoni-Baruch; Gamal Hassoun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.